MAP4K3 modulates cell death via the post-transcriptional regulation of BH3-only proteins
David Lam1, David Dickens, Elizabeth B Reid
1Cell Death Regulation Laboratory, Medical Research Council Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, United Kingdom.
Abstract:
Intracellular signal transduction networks involving protein kinases are important modulators of cell survival and cell death in multicellular organisms. Functional compromise of these networks has been linked to aberrant apoptosis in diseases such as cancer. To identify novel kinase regulators of cell death, we conducted an RNAi-based screen to identify modulators of the intrinsic apoptosis pathway. Using this approach, we identified MAP4K3 as a novel apoptosis inducer. Here, we present evidence that this pro-apoptotic kinase orchestrates activation of BAX via the concerted posttranscriptional modulation of PUMA, BAD, and BIM. Additionally, we found decreased levels of this kinase in pancreatic cancer samples, suggesting a tumor suppressor role for MAP4K3 in pancreatic tumorigenesis.
Insights
We identified MAP4K3, a novel protein kinase, as an inducer of programmed cell death (apoptosis). Lower MAP4K3 levels in pancreatic cancer suggest it acts as a tumor suppressor, regulating cell survival and death pathways.
Area of Science:
- Cell Biology
- Molecular Oncology
- Biochemistry
Background:
- Protein kinases regulate cell survival and death, with dysregulation linked to cancer.
- Aberrant apoptosis is a hallmark of cancer, necessitating identification of new regulators.
- Understanding cell death pathways is crucial for developing cancer therapies.
Purpose of the Study:
- To identify novel kinase regulators of the intrinsic apoptosis pathway.
- To investigate the role of MAP4K3 in apoptosis and cancer.
- To elucidate the molecular mechanisms by which MAP4K3 induces apoptosis.
Main Methods:
- Conducted an RNA interference (RNAi)-based screen to identify apoptosis modulators.
- Investigated MAP4K3's role in activating BAX, a key apoptosis effector.
- Analyzed MAP4K3 expression levels in pancreatic cancer patient samples.
Main Results:
- Identified MAP4K3 as a novel inducer of apoptosis.
- Demonstrated that MAP4K3 activates BAX through posttranscriptional modulation of PUMA, BAD, and BIM.
- Observed decreased MAP4K3 levels in pancreatic cancer tissues.
Conclusions:
- MAP4K3 is a pro-apoptotic kinase that regulates cell death.
- MAP4K3 functions as a tumor suppressor in pancreatic cancer by inducing apoptosis.
- Targeting MAP4K3 or its downstream effectors may offer new therapeutic strategies for pancreatic cancer.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
Cellular Injury V: Apoptosis and Autophagy
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway


